CA2417648C — Inactivation of antimicrobial agents by a phospholipid or a nonionic surfactant in methods of quantifying microorganisms
Assigned to Pola Pharma Inc · Expires 2011-01-25 · 15y expired
What this patent protects
A vital tissue segment (for example, skin), which has been infected with a microorganism and to which an antimicrobial agent is administered, is incubated in a medium containing a phospholipid and/or a nonionic surfactant and thus the viable count of the microorganism in the vita…
USPTO Abstract
A vital tissue segment (for example, skin), which has been infected with a microorganism and to which an antimicrobial agent is administered, is incubated in a medium containing a phospholipid and/or a nonionic surfactant and thus the viable count of the microorganism in the vital tissue is accurately determined.
Drugs covered by this patent
- Jublia (EFINACONAZOLE) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.